0Suppliers
3Customers
2Debt Items
12Related Chains

Praxis Precision Medicines, Inc. Suppliers

No suppliers on recordPraxis Precision Medicines, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Praxis Precision Medicines, Inc. Customers

TickerNameConfidenceEvidence
BCPE BCPE 92% The Company recorded the common stock sold to BCPE at its issuance date fair value of $ 38.95 per share, or $ 17.3 million in the aggregate
RAPP Rapport Therapeutics, Inc. 72% Reciprocal relationship from RAPP graph: into longer-term commercial supply agreements to fulfill and secure our production needs. While the drug substances used in our product candidates are manufac…
XENE Xenon Pharmaceuticals Inc. 72% Reciprocal relationship from XENE graph: Reciprocal relationship from PRAX graph: Reciprocal relationship from XENE graph: Reciprocal relationship from PRAX graph: Reciprocal relationship from XENE g…

Praxis Precision Medicines, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
PRAX-DEBT Debt stack $1.4M 90% Market cache reports total debt of $1.4M.
PRAX-DEBT-11873 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.

Praxis Precision Medicines, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Praxis Precision Medicines, Inc..

Praxis Precision Medicines, Inc. Ownership

HolderNameConfidenceEvidence
PRAX-OWNER-PERCEPTIVE-ADVISORS-LLC PERCEPTIVE ADVISORS LLC 90% 13F overlay lists PERCEPTIVE ADVISORS LLC as top holder; 300 tracked holders.

Praxis Precision Medicines, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
XENE Xenon Pharmaceuticals Inc. 100.00 1 ['customer']
BCPE BCPE 63.48 1 ['receiving']
BHC Bausch Health Companies Inc. 50.00 2
ORANY ORANGE 50.00 2
SUPN Supernus Pharmaceuticals, Inc. 50.00 2
NBIX Neurocrine Biosciences, Inc. 50.00 2
NMRA Neumora Therapeutics, Inc. 50.00 2
LXRX Lexicon Pharmaceuticals, Inc. 50.00 2
NPCE NeuroPace, Inc. 50.00 2
ANRO Alto Neuroscience, Inc. 50.00 2
AXSM Axsome Therapeutics, Inc. 50.00 2
RAPP Rapport Therapeutics, Inc. 36.29 1 ['customer']